Minocycline
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
100 mg twice dailyAcne: 100 mg daily in 1 or 2 divided doses
PHARMACOKINETICS
Molecular weight                           :457.5 %Protein binding                           :75 %Excreted unchanged in urine     : 5–10 Volume of distribution (L/kg)       :1–1.5half-life – normal/ESRD (hrs)      :11–26/12–18 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: possibly enhanced anticoagulant effect of coumarins and phenindione Oestrogens: possibly reduced contraceptive effect of oestrogens (risk probably small) Retinoids: possibly increased risk of benign intracranial hypertension – avoid concomitant use ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
Do not take iron preparations, indigestion remedies or phosphate binders at the same time of day as minocycline.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home